157 related articles for article (PubMed ID: 32216452)
21. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of ultrasound-guided radiofrequency ablation in the treatment of 36 renal cell carcinoma tumours compared with published results of using computed tomography guidance.
Davis K; Kielar A; Jafari K
Can Assoc Radiol J; 2012 Aug; 63(3 Suppl):S23-32. PubMed ID: 21145195
[TBL] [Abstract][Full Text] [Related]
23. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
[TBL] [Abstract][Full Text] [Related]
24. Distribution of renal tumor growth rates determined by using serial volumetric CT measurements.
Zhang J; Kang SK; Wang L; Touijer A; Hricak H
Radiology; 2009 Jan; 250(1):137-44. PubMed ID: 19092093
[TBL] [Abstract][Full Text] [Related]
25. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
Dai Y; Covarrubias D; Uppot R; Arellano RS
J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
[TBL] [Abstract][Full Text] [Related]
26. Vascular Tumor Burden as a New Quantitative CT Biomarker for Predicting Metastatic RCC Response to Antiangiogenic Therapy.
Smith AD; Zhang X; Bryan J; Souza F; Roda M; Sirous R; Zhang H; Vasanji A; Griswold M
Radiology; 2016 Nov; 281(2):484-498. PubMed ID: 27603788
[TBL] [Abstract][Full Text] [Related]
27. A Comparison of Cryoablation with Heat-Based Thermal Ablation for Treatment of Clinical T1a Renal Cell Carcinoma: A National Cancer Database Study.
Wu J; Chang J; Bai HX; Su C; Zhang PJ; Karakousis G; Reddy S; Hunt S; Soulen MC; Stavropoulos SW; Zhang Z
J Vasc Interv Radiol; 2019 Jul; 30(7):1027-1033.e3. PubMed ID: 31176590
[TBL] [Abstract][Full Text] [Related]
28. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
29. Renal mass biopsy and thermal ablation: should biopsy be performed before or during the ablation procedure?
Wells SA; Wong VK; Wittmann TA; Lubner MG; Best SL; Ziemlewicz TJ; Hinshaw JL; Lee FT; Abel EJ
Abdom Radiol (NY); 2017 Jun; 42(6):1773-1780. PubMed ID: 28184961
[TBL] [Abstract][Full Text] [Related]
30. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous cryoablation for renal cell carcinoma using ultrasound-guided targeting and computed tomography-guided ice-ball monitoring: radiation dose and short-term outcomes.
Kim DK; Won JY; Park SY
Acta Radiol; 2019 Jun; 60(6):798-804. PubMed ID: 30149751
[TBL] [Abstract][Full Text] [Related]
33. Survival benefits analyses of T1a renal cell carcinoma patients treated with microwave ablation.
Hou Q; Yu X; Cheng Z; Han Z; Liu F; Dou J; Yu J; Liang P
Eur J Radiol; 2021 Nov; 144():109951. PubMed ID: 34607288
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Contrast-Enhanced Ultrasound Scan (CEUS) and MRI in the follow-up of cryoablation for small renal tumors. Experience on 25 cases.
Zeccolini G; Del Biondo D; Cicero C; Casarin A; Guarise A; Celia A
Urologia; 2014; 81 Suppl 23():S1-8. PubMed ID: 24665032
[TBL] [Abstract][Full Text] [Related]
35. CT-Guided Microwave Ablation of 45 Renal Tumors: Analysis of Procedure Complexity Utilizing a Percutaneous Renal Ablation Complexity Scoring System.
Mansilla AV; Bivins EE; Contreras F; Hernandez MA; Kohler N; Pepe JW
J Vasc Interv Radiol; 2017 Feb; 28(2):222-229. PubMed ID: 27988263
[TBL] [Abstract][Full Text] [Related]
36. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors.
Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR
Radiology; 2003 Feb; 226(2):417-24. PubMed ID: 12563135
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
[TBL] [Abstract][Full Text] [Related]
38. Maximum tumor diameter is not an accurate predictor of renal cell carcinoma tumor volume.
Thiel DD; Jorns J; Lohse CM; Cheville JC; Thompson RH; Parker AS
Scand J Urol; 2013 Dec; 47(6):472-5. PubMed ID: 23883351
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
[TBL] [Abstract][Full Text] [Related]
40. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
